EIS Organising Committee

Mr. Alistair Laidlaw
President

EURETINA

PROF. RAMIN TADAYONI
PRESIDENT ELECT

EURETINA

Prof. Anat Loewenstein
General Secretary

EURETINA

Prof. Anat Loewenstein
General Secretary

EURETINA

Dr. Kourous Rezaei
Co-opted Board Member

EURETINA

Dr. Kourous Rezaei
Co-opted Board Member

EURETINA

Prof. Frank Holz
Past President

EURETINA

DARA CONLON
EXECUTIVE VICE-PRESIDENT

EURETINA

Contributors

Euretina is delighted to announce the following speakers and panellists confirmed to participate in the Inaugural EURETINA Innovation Summit (EIS) taking place on the 4th October 2023 at the RAI Amsterdam, preceding the EURETINA Annual Congress. 

We will be announcing further contributors as they are confirmed.

Ms. Megan Baldwin
Managing Director & CEO

OPTHEA

Mr. Pierre Billardon
CEO

DUTCH OPHTHALMIC RESEARCH CENTRE

Kerrie Brady BPharm MBA MS
CEO & President

OCUTERRA THERAPUTICS

Dr. Christopher Brittain
VP Global Head of Ophthalmology Product Development

GENENTECH

Ms. Anne Marie Cairns
Chief Clinical Officer

OPTOS

Mr. Philippe Charles
VP EMEA

VISIONIX

Mr. Victor Chong
VP, Global Head of Retina

JANSSEN R&D LLC

Dr. Thomas Ciulla
Chief Medical Advisor – Retina & Chair Scientific Advisory Board

CLEARSIDE BIOMEDICAL

 

Dr. Anupam Dalal
Chief Investment Officer

ACUTA CAPITAL PARTNERS

Mr. Andrew Dick
CEO

CIRRUS

Mr. Sascha Fauser
Global Head of Ophthalmology

ROCHE

Dr. Laurent Fischer
President & CEO

ADVERUM BIOTECHNOLOGIES

Dr. Cedric Francois
President & CEO

APELLIS SWITZERLAND GMBH

Ms. Anta Gkelou
Principal Capital Strategy

SOFINNOVA PARTNERS

Dr. Ulrike Graefe-Mody
Global Head Retinal Health

BOEHRINGER INGELHEIM

Mr. Paul Hallen
VP Global Head Retina & Glaucoma

ALCON

Dr. Naama Hammel
Clinical Research Scientist

GOOGLE HEALTH

Mr. Yehia Hashad
EVP of R&D and CMO

BAUSCH + LOMB

Dr. Jill Hopkins
Global Head Retinal Health

NOVARTIS

Dr. Robert Kim
Chief Medical Officer

4D MOLECULAR THERAPEUTICS

Mr. Shervin Korangy
President & CEO

BVI

Dr. Sergio Leal
Director, Global Clinical Leader

BAYER

Ms. Nancy Lurker
President & CEO

EyePoint Pharmaceuticals

Dr. Stephanie Magazzeni
Head of Digital Research and Innovation

ZEISS

Dr. Helge Menz
Assistant to the General Manager

PHARMPUR GMBH

Mr. Kester Nahen
CEO

NOTAL VISION

Mr. Ram Palanki
Executive Vice President, Commercial Strategy & Operations

REGENXBIO INC.

Ms. Henrijette Richter
Managing Partner

SOFINNOVA PARTNERS

Mr. Glenn P. Sblendorio
President & CEO

IVERIC BIO

Dr. Mathias Schifflers
GMA Head of Eyecare

ABBVIE EYECARE

Mr. Ron Schneider
CEO Beyeonics Surgical

BEYEONICS

Ms. Arianna Schoess Vargas
Managing Director

HEIDELBERG ENGINEERING GMBH

DR. Riad Sherif
CEO

OCULIS

Ms. Mina Sooch
CEO and Founder

OCUPHIRE PHARMA

Mr. Christoph Spuhler
CEO

ACUSURGICAL

Mr. Naaman Tammuz
CPO & Co-founder

BITFOUNT

Mr. Edward Van Wezel
Managing Partner

BIOGENERATION VENTURES

Dr. Kerstin Wickstrom
Expert, Clinical Unit

ICELANDIC MEDICINES AGENCY